Literature DB >> 31773019

Cancer Cell Metabolism: Implications for X-ray and Particle Radiation Therapy.

Mathieu Sertorio1, John P Perentesis1, Ralph E Vatner2,3, Anthony E Mascia3, Yi Zheng1, Susanne I Wells1.   

Abstract

Advances in radiation delivery technologies and immunotherapy have improved effective cancer treatments and long-term outcomes. Experimental and clinical trials have demonstrated the benefit of a combination of radiation therapy and immunotherapy for tumor eradication. Despite precise radiation dose delivery that is achievable by particle therapy and benefits from reactivating the antitumor immune response, resistance to both therapeutic strategies is frequently observed in patients. Understanding the biological origins of such resistance will create new opportunities for improved cancer treatment. Cancer metabolism and especially a high rate of aerobic glycolysis leading to overproduction and release of lactate is one such biological process favoring tumor progression and treatment resistance. Because of their known protumor effects, aerobic glycolysis and lactate production are potential targets for increased efficacy of radiation alone or in combination with immunotherapy. In the following review, we present an overview of the interplay of cancer cell lactate metabolism with the tumor microenvironment and immune cells. We discuss how a deeper understanding and careful modulation of lactate metabolism and radiation therapy might exploit this interplay for improved therapeutic outcome. ©Copyright 2018 International Journal of Particle Therapy.

Entities:  

Keywords:  aerobic glycolysis; immunotherapy; lactate; radiation therapy; tumor metabolism

Year:  2018        PMID: 31773019      PMCID: PMC6871586          DOI: 10.14338/IJPT-18-00023.1

Source DB:  PubMed          Journal:  Int J Part Ther        ISSN: 2331-5180


  59 in total

1.  Inhibitory effect of tumor cell-derived lactic acid on human T cells.

Authors:  Karin Fischer; Petra Hoffmann; Simon Voelkl; Norbert Meidenbauer; Julia Ammer; Matthias Edinger; Eva Gottfried; Sabine Schwarz; Gregor Rothe; Sabine Hoves; Kathrin Renner; Birgit Timischl; Andreas Mackensen; Leoni Kunz-Schughart; Reinhard Andreesen; Stefan W Krause; Marina Kreutz
Journal:  Blood       Date:  2007-01-25       Impact factor: 22.113

2.  Extracellular acidosis promotes neutrophil transdifferentiation to MHC class II-expressing cells.

Authors:  Boris K Pliyev; Alexander B Sumarokov; Lyudmila I Buriachkovskaia; Mikhail Menshikov
Journal:  Cell Immunol       Date:  2011-08-30       Impact factor: 4.868

3.  Nuclear physics in particle therapy: a review.

Authors:  Marco Durante; Harald Paganetti
Journal:  Rep Prog Phys       Date:  2016-08-19

4.  Ras inhibition in glioblastoma down-regulates hypoxia-inducible factor-1alpha, causing glycolysis shutdown and cell death.

Authors:  Roy Blum; Jasmine Jacob-Hirsch; Ninette Amariglio; Gideon Rechavi; Yoel Kloog
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

Review 5.  The Swedish Council on Technology Assessment in Health Care (SBU) systematic overview of radiotherapy for cancer including a prospective survey of radiotherapy practice in Sweden 2001--summary and conclusions.

Authors:  Ulrik Ringborg; David Bergqvist; Bengt Brorsson; Eva Cavallin-Ståhl; Jeanette Ceberg; Nina Einhorn; Jan-Erik Frödin; Johannes Järhult; Gunilla Lamnevik; Christer Lindholm; Bo Littbrand; Anders Norlund; Urban Nylén; Måns Rosén; Hans Svensson; Torgil R Möller
Journal:  Acta Oncol       Date:  2003       Impact factor: 4.089

6.  Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression.

Authors:  Chih-Hao Chang; Jing Qiu; David O'Sullivan; Michael D Buck; Takuro Noguchi; Jonathan D Curtis; Qiongyu Chen; Mariel Gindin; Matthew M Gubin; Gerritje J W van der Windt; Elena Tonc; Robert D Schreiber; Edward J Pearce; Erika L Pearce
Journal:  Cell       Date:  2015-08-27       Impact factor: 41.582

7.  Deficiency in homologous recombination renders Mammalian cells more sensitive to proton versus photon irradiation.

Authors:  Nicole Grosse; Andrea O Fontana; Eugen B Hug; Antony Lomax; Adolf Coray; Marc Augsburger; Harald Paganetti; Alessandro A Sartori; Martin Pruschy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-11-13       Impact factor: 7.038

Review 8.  Glutamine at focus: versatile roles in cancer.

Authors:  Humberto De Vitto; Juan Pérez-Valencia; James A Radosevich
Journal:  Tumour Biol       Date:  2015-12-24

9.  THE METABOLISM OF TUMORS IN THE BODY.

Authors:  O Warburg; F Wind; E Negelein
Journal:  J Gen Physiol       Date:  1927-03-07       Impact factor: 4.086

Review 10.  Combining radiotherapy and ipilimumab induces clinically relevant radiation-induced abscopal effects in metastatic melanoma patients: A systematic review.

Authors:  Rodolfo Chicas-Sett; Ignacio Morales-Orue; Delvys Rodriguez-Abreu; Pedro Lara-Jimenez
Journal:  Clin Transl Radiat Oncol       Date:  2017-12-23
View more
  1 in total

Review 1.  Stimuli-Responsive Nanoparticles for Controlled Drug Delivery in Synergistic Cancer Immunotherapy.

Authors:  Jin Zhang; Yandai Lin; Zhe Lin; Qi Wei; Jiaqi Qian; Renjie Ruan; Xiancai Jiang; Linxi Hou; Jibin Song; Jianxun Ding; Huanghao Yang
Journal:  Adv Sci (Weinh)       Date:  2021-12-19       Impact factor: 16.806

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.